News  Donate!

CNS Symptoms and Meaningful Clinical Trial Endpoints - 2025 MDF Conference

A summary from the clinical endpoint workshop focusing on CNS clinical presentations and meaningful endpoints in clinical trials for myotonic dystrophy.

Presented by: Eric Wang, PhD, Associate Professor, Molecular Genetics & Microbiology, University of Florida, MDF Medical and Scientific Advisory Committee, MDF National Advocacy Committee

Thank you to our 2025 MDF Conference Sponsors for helping make this event possible:

  • Lead Sponsor: Avidity Biosciences
  • Diamond Sponsors: Dyne Therapeutics and Arthex Biotech
  • Platinum Sponsors: PepGen and Vertex Pharmaceuticals
  • Gold Sponsor: Sanofi
  • Bronze Sponsor: Lupin Neurosciences

Explore our other sessions and read about the incredible 2025 MDF Conference in Indianapolis, Indiana!